136 related articles for article (PubMed ID: 3081934)
1. Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.
Scatton B; Loo H; Dennis T; Benkelfat C; Gay C; Poirier-Littre MF
Psychopharmacology (Berl); 1986; 88(2):220-5. PubMed ID: 3081934
[TBL] [Abstract][Full Text] [Related]
2. [Study of noradrenaline metabolism in depressed patients by the determination of plasma dihydroxyphenylethylene glycol].
Lôo H; Scatton B; Dennis T; Benkelfat C; Gay C; Poirier-Littré MF; Garreau M; Vanelle JM; Olié JP; Deniker P
Encephale; 1983; 9(4):297-316. PubMed ID: 6671452
[TBL] [Abstract][Full Text] [Related]
3. Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
Lôo H; Benkelfat C; Poirier MF; Vanelle JM; Olié JP; Dennis T; Scatton B
Neuropsychobiology; 1986; 15(2):62-7. PubMed ID: 3762900
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patients.
Lôo H; Dennis T; Vanelle JM; Rouquier L; Poirier-Littré MF; Garreau M; Benkelfat C; Sechter D; Scatton B
Biol Psychiatry; 1986 Aug; 21(10):900-6. PubMed ID: 2874842
[TBL] [Abstract][Full Text] [Related]
5. [Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol].
Loo H; Scatton B; Poirier MF; Benkelfat C; Dennis T; Vanelle JM; Garreau M; Sechter D
Presse Med; 1985 Jun; 14(25):1363-6. PubMed ID: 3161030
[TBL] [Abstract][Full Text] [Related]
6. Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients.
Azorin JM; Karege F; Valli M; Pringuey D; Joanny P; Tissot R
Neuropsychobiology; 1988; 20(2):67-73. PubMed ID: 3075724
[TBL] [Abstract][Full Text] [Related]
7. Plasma 3,4-dihydroxyphenylethyleneglycol levels in depressed patients with and without abnormal dexamethasone suppression.
Lôo H; Benkelfat C; Poirier MF; Gay C; Askienazy S; Dennis T; Scatton B
Neuropsychobiology; 1986; 15(2):68-72. PubMed ID: 3762901
[TBL] [Abstract][Full Text] [Related]
8. Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects.
Dennis T; Benkelfat C; Touitou Y; Auzeby A; Poirier MF; Scatton B; Lôo H
Psychopharmacology (Berl); 1986; 90(4):471-4. PubMed ID: 3101103
[TBL] [Abstract][Full Text] [Related]
9. Plasma MHPG and age at onset in depressed patients.
Karege F; Bovier P; Gaillard JM; Tissot R
Psychiatry Res; 1989 Oct; 30(1):103-5. PubMed ID: 2594867
[No Abstract] [Full Text] [Related]
10. Apparent phase advance in diurnal MHPG rhythm in depression.
Gwirtsman HE; Halaris AE; Wolf AW; DeMet E; Piletz JE; Marler M
Am J Psychiatry; 1989 Nov; 146(11):1427-33. PubMed ID: 2817113
[TBL] [Abstract][Full Text] [Related]
11. Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.
Halbrügge T; Gerhardt T; Ludwig J; Heidbreder E; Graefe KH
Life Sci; 1988; 43(1):19-26. PubMed ID: 3386411
[TBL] [Abstract][Full Text] [Related]
12. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of noradrenaline and 3,4-dihydroxyphenylethyleneglycol under conditions of enhanced sympathetic activity.
Ludwig J; Gerhardt T; Halbrügge T; Walter J; Graefe KH
Eur J Clin Pharmacol; 1988; 35(3):261-7. PubMed ID: 3181279
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic function and the dexamethasone suppression test in depression.
Morinobu S; Satoh H; Endoh M; Totsuka S
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
[TBL] [Abstract][Full Text] [Related]
15. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
Halbreich U; Sharpless N; Asnis GM; Endicott J; Goldstein S; Vital-Herne J; Eisenberg J; Zander K; Kang BJ; Shindledecker R
Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
[TBL] [Abstract][Full Text] [Related]
16. Plasma noradrenaline and its deaminated metabolites in essential hypertension and pheochromocytoma.
Mizukoshi M; Hano T; Kuchii M; Nishio I; Masuyama Y
Jpn Circ J; 1985 Sep; 49(9):1035-42. PubMed ID: 4068201
[TBL] [Abstract][Full Text] [Related]
17. Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycle.
Poirier MF; Lôo H; Dennis T; Le Fur G; Scatton B
Neuropsychobiology; 1985; 14(4):165-9. PubMed ID: 3835494
[TBL] [Abstract][Full Text] [Related]
18. Plasma MHPG in rapid cyclers and healthy twins.
Jimerson DC; Nurnberger JI; Post RM; Gershon ES; Kopin IJ
Arch Gen Psychiatry; 1981 Nov; 38(11):1287-90. PubMed ID: 7197905
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
Azorin JM; Raucoules D; Valli M; Levy C; Lancon C; Luccioni JM; Tissot R
Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative results.
Loo H; Benkelfat C; Scatton B; Dennis T; Poirier MF; Vanelle JM; Olie JP; Susini de Luca H
Adv Biochem Psychopharmacol; 1985; 40():99-102. PubMed ID: 4025042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
